scispace - formally typeset
A

Arne Astrup

Researcher at University of Copenhagen

Publications -  902
Citations -  77453

Arne Astrup is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Weight loss & Overweight. The author has an hindex of 114, co-authored 866 publications receiving 68877 citations. Previous affiliations of Arne Astrup include Copenhagen University Hospital & University of South Australia.

Papers
More filters
Journal ArticleDOI

Calcium reduces risk of pre-eclampsia.

TL;DR: A diet that provides 1000 mg per day calcium, or a dietary supplement of calcium (and vitamin D), is a cheap means of reducing the risk of pre-eclampsia in women at increased risk and in women with low calcium intakes, and has other health benefi ts while doing no harm.
Journal ArticleDOI

Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials.

TL;DR: The three-fold increased risk of withdrawal from treatment on nalmefene due to adverse events is a matter of safety concern and the nature of these adverse events cannot be elucidated further without access to individual patients data.
Journal ArticleDOI

Obesity: Have new guidelines overlooked the role of diet composition?

TL;DR: In this article, the authors show that new US guidelines for the management of overweight and obesity have disregarded robust evidence from intervention trials demonstrating the importance of dietary factors for weight control and disease prevention.
Patent

Method for prediction of lipoprotein content from nmr data

TL;DR: In this article, a method of preparing regression coefficients for predicting the quantity of a component of a lipoprotein entity in a biological sample from NMR spectral data was proposed, which is based on the regression coefficients.
Journal ArticleDOI

Habitual dietary phosphorus intake and urinary excretion in chronic kidney disease patients: a 3-day observational study.

TL;DR: In this population of CKD patients stage 3–4 the daily phosphorus intake was above the recommended and the data indicate that a single 24-h urine collection is sufficient to estimate the individual phosphorus excretion.